effects. This is an adequate and feasible model that could be translated into a therapeutic approach for clinical assays in neurodegenerative diseases.
INTRODUCTION
the time they spent walking on the rotating rod at a constant speed of 4 rpm. Also, their maximum walking speed was noted, by increasing the speed at a constant rate of 4 to 40 rpm in a 1-minute interval until the animal fell from the rotarod. The mice were placed on the rotarod 10 times for each test, and the average value was calculated. These tests were performed for a total of 5 weeks, until the mice reached the age of 8 weeks.
Tissue Fixation and Immunohistochemistry
After the 5-week rotarod tests, the mice were anesthetized with isofluorane and fixed by intra-cardiac perfusion with 4% filtered paraformaldehyde (PFA) in phosphate buffer (pH 7.4). The brain was carefully excised and kept in 4% PFA overnight. After fixation, the samples were cryoprotected by increasing concentrations of sucrose (up to 30%) and finally embedded in Neg-50
Frozen Section Medium (Richard-Allan Scientific, Kalamazoo, Michigan), frozen, and stored at -20ºC. Thirty micrometer sagittal sections were obtained using a Microm HM525 cryostat and mounted on slides.
The sections were first incubated at room temperature in 10% goat serum, 5% bovine albumin, 0.25% triton and PBS to permeate the tissue and block non-specific binding. Afterwards, the sections were incubated overnight at room temperature with the primary antibody, diluted in blocking solution (10% goat serum, 5% bovine albumin and PBS). The following primary antibodies were used: rabbit anti-calbindin (1:3000, Swiss Antibodies, Bellinzona, Switzerland), mouse anti-GFP (1:200, Molecular Probes, Eugene, OR), rabbit anti-GDNF (1:100, Santa Cruz Biotechnology, Santa Cruz, CA), rabbit anti-BDNF (1:200, Santa Cruz Biotechnology, Santa Cruz, CA), sheep anti-neurotrophin-4/5 (NT-4/5, 1:100, Chemicon/Millipore, Billerica, MA), sheep anti-nerve growth factor (NGF, 1:500, Chemicon/Millipore, Billerica, MA) and sheep anti-neurotrophin-3 (NT-3, 1:100, Chemicon/Millipore, Billerica, MA).
The following day, the sections were incubated with the secondary antibody.
For GFP staining, we used anti-mouse Alexa Green (1:500, Molecular Probes), and for the other antibodies biotinylated secondary antibodies were used (1:200, Vector Laboratories, Burmingham, California) followed by an incubation with streptavidin conjugated with Cy3 (1:500). DAPI (Molecular Probes) was used to stain nuclei. In some cases, the secondary antibody used was conjugated with peroxidase for DAB staining (Applichem, Germany), and the tissue counterstained with cresyl violet (Acros Organics, Belgium). Histological samples were observed under a fluorescence microscope (Leica DMR, Leica Microsystems) and micrographs taken with a confocal microscope (Leica DMR).
Cell Count
To count the number of Purkinje cells and grafted cells, immunohistochemistry was performed for calbindin and GFP, respectively. Then, the positive cells in the 10 center-most sections and the average number per section was calculated in the control and experimental cerebella.
This was also performed to count the number of fused cells, as well as the grafted cells expressing neurotrophic factors.
Post-transplant Cerebellar Culture and Immunocytochemistry
After the MSC transplant and rotarod assay, 3 mice from 3 different experiments were sacrificed and brain extracted. The cerebellum was isolated and placed in a culture dish with D-MEM, minced into small pieces and mechanically disaggregated. The tissue was then centrifuged and the resulting pellet was re-suspended in standard MSC culture medium (described previously) and placed in several 35 mm treated culture dishes.
After 5 days of culture, the cultures were fixed with 4% paraformaldehyde and stained for GFP and calbindin. The staining protocol used was similar to the tissue staining commented previously, only 0.025% Triton was used to permeabilize the cells. The samples were visualized under the fluorescence microscope.
Statistical Analysis
Statistical significance between control and experimental groups were calculated with SPSS v11.0 software, using ANOVA and the non-parametric Mann Whitney test. Both experimental groups seemed to obtain increasingly higher scores with each passing week, which was not observed in the controls. The average deviations of the charts, particularly in the MSC group, are very large, due to the variability of each mouse. For example, one of the MSC mice was capable of walking for over 400 seconds. Despite the variability, it was clear that the MSC-treated mice obtained significantly better results than the control mice in this test (p < 0.05, p < 0.001 with Mann Whitney test).
As for the rotarod test at increasing speeds, on average, the control mice were capable of walking until reaching speeds of 9-12 rpm, while the sham averaged 9 rpm. As for the treated mice, the BM mice had scores that were similar to the controls (9-13 rpm) while the MSC reached slightly higher scores (12-14 rpm). Except for one of the weeks, the MSC-treated mice presented significantly higher values compared to the controls (p < 0.05, p < 0.001 with Mann Whitney).
Thus, MSC mice were capable of walking on the rotarod for much longer periods of time, indicating a significant improvement in the motor coordination of these mice.
2. After 1 month, mesenchymal stem cells have migrated throughout the cerebellum using the white matter Several non-symptomatic treated mice were sacrificed at 1 month of age, to confirm that the injected cells survived the surgical procedure (n=5). In these mice, the transfected cells could clearly be detected throughout the whole cerebellum ( Figure 2 ). These cells were either spherical-shaped or elongated (Figure 2A-E) . From the injection site, it was possible to detect GFP+ cells traveling around the exterior of the cerebellum, in between the lobes, until finally penetrating through the molecular layer into the white matter ( Figure   2C -E). Once in the white matter, the cells migrated throughout the whole cerebellum. The vast majority of the cells were located in the white matter, although a few were found in the various layers of the cerebellar cortex. As for the BMC-treated mice, the majority of the cells were detected outside the cerebellum ( Figure 2F ). These cells were spherical-shaped, and did not seem to be capable of penetrating into the cerebellar tissue as seen with MSC.
Thus, transplanted mesenchymal stem cells, but not whole bone marrow cells, are capable of integrating into the cerebellar tissue and migrate throughout the cerebellum. Two months after the transplant, once the behavior assays have been completed, the MSC-treated mice were sacrificed and analyzed (n = 10). In this case, the majority of the transplanted cells were not located in the white matter, as seen after 1 month. At this moment, the GFP+ cells were generally located either throughout the cerebellar parenchyma forming multiple branched or spherical structures, or in the Purkinje cell layer (Fig. 3F, 4A ).
Clusters of grafted cells were always localized close or in physical contact
with the surviving Purkinje cells (Fig. 4B) , as well as surrounding blood vessels (Fig. 4C) . In some mice, it was possible to detect a small fraction of GFP+ Purkinje cells with 2 nuclei (Fig. 4D-E (Fig. 5A) . The cells were mainly spherical-shaped, and many presented 2 nuclei (Fig. 5B-C) . Also, some were calbindin positive. These cells did not proliferate in the 7 days the culture was maintained. 
